NorthShore University HealthSystem provides an established pancreatico-biliary and liver disease program that is well-recognized in Illinois and the Midwest. This program offers patients with pancreatico-biliary disease a comprehensive, multidisciplinary approach that is patient-centered. The physicians and nurses who treat patients with pancreatico-biliary disease are empathetic and caring, and utilize state-of-the-art technologies, surgical techniques and medical protocols to work toward the best possible outcome for each patient.
Patients needing care through this program suffer from a wide variety of diseases including: pancreatic cancer, cholangiocarcinoma (bile duct cancer), gallbladder cancer, bile duct injury (from trauma or laparoscopic cholecystectom), liver cancer, metastatic colorectal cancer, benign liver and pancreas cyst or tumors and chronic pancreatitis.
Pancreatic cancer research is an important element in the hepato-pancreatico-biliary program at NorthShore University HealthSystem. A major component of non-therapeutic research is now in place with the approval of the collaborative NU and NSUHS Clinical Pancreatic Cancer Database. In order to find new and better treatment for pancreatic cancer, specimens are collected and stored for research purposes in the NorthShore University HealthSystem tissue bank. Therapeutic research is expanding with the recruitment of specialized surgeons and collaborative neoadjuvant and adjuvant clinical trials. In addition, a Phase II vaccine study to prevent disease recurrence is on the way to open soon here. The busy surgeons see steadily increasing numbers of patients diagnosed with pancreatic cancer who come to their clinics because of NorthShore University HealthSystem's excellent reputation and because of our status as a major research institution.
NorthShore University HealthSystem employs two dedicated hepato-pancreatico-biliary surgeons: Mark Talamonti, MD, and Marshall Baker, MD. Each of these surgeons has had advanced fellowship training specifically focused on pancreas, liver and biliary disease at the best training programs in the United States. These surgeons employ the most advanced surgical approaches to these diseases and are well-versed and experienced in minimally invasive (laparoscopic) pancreas and liver resection using these techniques whenever possible. They make great effort to provide a procedure that provides sound cancer care and is tailored to and appropriate for individual patients and their diagnoses.
Our gastroenterologists have all had advanced fellowship training in interventional gastroenterology and are very experienced in state of the art techniques that enable appropriate preoperative diagnosis. These include endoscopic ultrasound of the pancreas and liver and endoscopic contrast imaging/stenting for biliary strictures.
Our medical oncologists and radiation oncologists have all had advanced fellowship training specifically focused on gastrointestinal oncology. They offer the most recent chemotherapy protocols and state of the art stereotactic guidance systems for post operative radiation in effort to provide site direct adjuvant therapy that is well-tolerated by the patient.